Actualités dans la gestion des syndromes coronariens aigus
Actualités dans la gestion des syndromes coronariens aigus Actualités dans la gestion des syndromes coronariens aigus
Reperfusion Therapy Recommendations Class LOE • Indicated in all pts with chest pain/discomfort of < 12 h and with persistent ST-segment elevation or (presumed) new LBBB I A • Should be considered if there is clinical and/or ECG evidence of ongoing ischaemia if symptoms started > 12 h before IIa C • Reperfusion (PCI) in stable pts presenting > 12 h to 24 h after symptom onset IIb B • PCI of totally occluded infarct artery in stable pts without signs of ischaemia > 24 h after symptom onset III B
Angiography after Fibrinolytic Therapy Recommendations Class LOE Evidence of failed fibrinolysis or uncertainty about success: immediate IIa B Recurrent ischaemia, reocclusion after initial successful fibrinolysis: immediate I B Evidence of successful fibrinolysis: within 3 to 24 h after start of fibrinolytic therapy IIa A In unstable patients who did not receive reperfusion therapy: immediate I C In stable patients who did not receive reperfusion therapy: before discharge IIb C
- Page 1 and 2: Actualités s 2010 pour la prise en
- Page 3 and 4: douleur thoracique douleur persista
- Page 5 and 6: Recommandations Européennes (ESC 2
- Page 7 and 8: Le seul objectif du traitement de l
- Page 9 and 10: Reperfusion Therapy: Important Time
- Page 11: Stratégie de reperfusion d’un SC
- Page 15 and 16: Fibrinolytic Therapy: Antithromboti
- Page 17 and 18: Thrombolysis vs primary PCI : 1 Yr
- Page 19 and 20: Peut on améliorer les délais % d
- Page 21 and 22: Décès, FV, choc cardiogénique à
- Page 23 and 24: Clopidogrel response variability fo
- Page 25 and 26: 15 TRITON study : Primary Endpoint
- Page 27 and 28: * Range ±7 7 days 3602 pts with ST
- Page 29: 1-Year Death or Reinfarction Death
- Page 32 and 33: CK release during reperfusion CK re
- Page 34 and 35: Recommandations Européennes (ESC 2
- Page 36 and 37: Critères pour le bilan coronarogra
- Page 38 and 39: ACUITY - Primary Results UFH/Enoxap
- Page 40 and 41: 96-Hour Primary Efficacy Results Ro
- Page 42 and 43: ABOARD : Individual Ischemic Endpoi
Angiography after Fibrinolytic Therapy<br />
Recommendations C<strong>la</strong>ss LOE<br />
Evidence of failed fibrinolysis or uncertainty about success:<br />
immediate<br />
IIa<br />
B<br />
Recurrent ischaemia, reocclusion after initial successful<br />
fibrinolysis: immediate<br />
I<br />
B<br />
Evidence of successful fibrinolysis: within 3 to 24 h after<br />
start of fibrinolytic therapy<br />
IIa<br />
A<br />
In unstable patients who did not receive reperfusion<br />
therapy: immediate<br />
I<br />
C<br />
In stable patients who did not receive reperfusion therapy:<br />
before discharge<br />
IIb<br />
C
Change language